Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| A-15174.2b | Other Identifier | HRPO | |
| K141341 | Other Identifier | Other |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| InBios International, Inc. | INDUSTRY |
| Institut Pasteur of Tunis, Tunisia | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of the study is to evaluate the sensitivity and specificity of CL Detect, in subjects with suspected CL in Tunisia.
Subjects were selected based on clinical appearance of the skin lesion characteristics of cutaneous leishmaniasis (CL). Study compared the CL Detect Rapid Test vs microscopic identification of Leishmania amastigotes in a stained lesion sample. Two diagnostic samples were collected from the subjects lesion in the following order: 1) obtained with a dental broach for use with the CL Detect Rapid Test and 2) a second sample was obtained by scraping for use in the microscopic identification of amastigotes. Samples were analyzed by microscopy and CL Detect Repaid Test by different operators who evaluated each sample independently blinded to the other assay result.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| CL Detect Rapid Test and Microsopy Samples | Samples taken to be evaluated in the CL Detect and Microscopy assays |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| No Intervention | Other |
|
| Measure | Description | Time Frame |
|---|---|---|
| Positive Result Comparison: CL Detect Rapid Test With Microscopy and Culture Results | Comparison of CL Detect Rapid Test positive results with Microscopy and Culture results. Note: only data where results for all three methods were available were included in the analysis. | within 1 hour after taking samples |
Not provided
Not provided
Inclusion Criteria:
At least 18 years of age and generally healthy
Subject able to give written informed consent
Subject has a lesion suspicious for leishmaniasis that satisfies the following criteria for an index lesion:
In the opinion of the investigator, the subject is capable of understanding and complying with the protocol
Exclusion Criteria:
• Received treatment for leishmaniasis within the last 2 months prior to signing consent, with the exception of mercurochrome
Not provided
Not provided
Not provided
Primary care clinic
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Afif Ben Salah, MD PhD | Institut Pasteur de Tunis | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Primary Health Clinic | Gafsa | Gafsa Governorate | Tunisia | |||
| Primary Health Clinics |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
168 subjects were enrolled in the regions of Sidi Bouzid and Gafsa, Tunisia
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | CL Detect Rapid Test and Microsopy Samples | Samples taken to be evaluated in the CL Detect and Microscopy assays No Intervention |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | CL Detect Rapid Test and Microsopy Samples | Samples taken to be evaluated in the CL Detect and Microscopy assays No Intervention |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Positive Result Comparison: CL Detect Rapid Test With Microscopy and Culture Results | Comparison of CL Detect Rapid Test positive results with Microscopy and Culture results. Note: only data where results for all three methods were available were included in the analysis. | Posted | Count of Participants | Participants | within 1 hour after taking samples |
|
48 hours after taking of samples
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | CL Detect Rapid Test and Microsopy Samples | Samples taken to be evaluated in the CL Detect and Microscopy assays No Intervention |
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Afif Gen Salah, MD, PhD | Institut Pasteur of Tunis | 011-216-71-792-429 | noemailavailable@no.com |
Not provided
| ID | Term |
|---|---|
| D012876 | Skin Diseases, Parasitic |
| D007896 | Leishmaniasis |
| ID | Term |
|---|---|
| D010272 | Parasitic Diseases |
| D007239 | Infections |
| D012874 | Skin Diseases, Infectious |
| D012871 | Skin Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Sidi Bouzid |
| Sidi Bouzid Governorate |
| Tunisia |
| years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Race/Ethnicity, Customized | Count of Participants | Participants |
|
| Region of Enrollment | Number | participants |
|
| Lesion Age | Mean | Standard Deviation | days |
|
| Lesion Characteristics | Count of Participants | Participants |
|
| Lesion Location | Count of Participants | Participants |
|
Data for Culture results
|
|
| 0 |
| 168 |
| 0 |
| 168 |
| 0 |
| 168 |
Not provided
Not provided
| D017437 |
| Skin and Connective Tissue Diseases |
| D056986 | Euglenozoa Infections |
| D011528 | Protozoan Infections |
| D000079426 | Vector Borne Diseases |